Sirtinol Inhibits Neutrophil Elastase Activity and Attenuates Lipopolysaccharide-Mediated Acute Lung Injury in Mice

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tsai, Yung Fong ^a,b   Yu, Huang Ping ^a,b   Chang, Wen Yi ^a,c   Liu, Fu Chao ^a,b   Huang, Zhen Cheng ^b   Hwang, Tsong Long ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMIDE DERIVATIVE; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDE; NAPHTHOL DERIVATIVE; PEROXIDASE; PROTEIN KINASE; SIRTINOL;

ACUTE LUNG INJURY; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DISEASE MODEL; ENZYMOLOGY; HUMAN; MALE; METABOLISM; MOUSE; NEUTROPHIL; PATHOLOGY;

ACUTE LUNG INJURY; ANIMALS; BENZAMIDES; DISEASE MODELS, ANIMAL; HUMANS; LEUKOCYTE ELASTASE; LIPOPOLYSACCHARIDES; MALE; MICE; NAPHTHOLS; NEUTROPHILS; PEROXIDASE; PROTEIN KINASES;

EID: 84929209754     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08347     Document Type: Article

References (44)

1. Pierrakos, C. & Vincent, J. L. The changing pattern of acute respiratory distress syndrome over time: a comparison of two periods. Eur Respir J 40, 589-595 (2012).
2. Davey, A., McAuley, D. F. & O'Kane, C. M. Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair. Eur Respir J 38, 959-970 (2011).
3. Griffin, K. L. et al. 2-O, 3-O-desulfated heparin inhibits neutrophil elastaseinduced HMGB-1 secretion and airway inflammation. Am J Respir Cell Mol Biol 50, 684-689 (2014).
4. Henriksen, P. A. The potential of neutrophil elastase inhibitors as antiinflammatory therapies. Curr Opin Hematol 21, 23-28 (2014).
5. Hoenderdos, K. & Condliffe, A. The neutrophil in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 48, 531-539 (2013).
6. Gadek, J. E. & Pacht, E. R. The protease-antiprotease balance within the human lung: implications for the pathogenesis of emphysema. Lung 168 Suppl, 552-564 (1990).
7. Balfour-Lynn, I. M. The protease-antiprotease battle in the cystic fibrosis lung. J R Soc Med 92 Suppl 37, 23-30 (1999).
8. Senior, R. M. & Anthonisen, N. R. Chronic obstructive pulmonary disease (COPD). Am J Respir Crit Care Med 157, S139-147 (1998).
9. Perlmutter, D. H. Alpha-1-antitrypsin deficiency: biochemistry and clinical manifestations. Ann Med 28, 385-394 (1996).
10. Yokoyama, T. et al. Acute lung injury with alveolar hemorrhage due to a novel swine-origin influenza A (H1N1) virus. Intern Med 49, 427-430 (2010).
11. Zeiher, B. G. et al. Neutrophil elastase inhibition in acute lung injury: results of the STRIVE study. Crit Care Med 32, 1695-1702 (2004).
12. Villalba, J. M. & Alcain, F. J. Sirtuin activators and inhibitors. Biofactors 38, 349-359 (2012).
13. Liu, F. C. et al. Hemeoxygenase-1 upregulation is critical for sirtinol-mediated attenuation of lung injury after trauma-hemorrhage in a rodent model. Anesth Analg 108, 1855-1861 (2009).
14. Liu, F. C., Tsai, Y. F. & Yu, H. P. Sirtinol attenuates trauma hemorrhage-induced hepatic injury through Akt-dependent pathway in rats. J Trauma Acute Care Surg 74, 1027-1032 (2013).
15. Hwang, T. L., Yeh, S. H., Leu, Y. L., Chern, C. Y. & Hsu, H. C. Inhibition of superoxide anion and elastase release in human neutrophils by 3'-isopropoxychalcone via a cAMP-dependent pathway. Br J Pharmacol 148, 78-87 (2006).
16. Anderson, R., Theron, A. J., Gravett, C. M., Steel, H. C., Tintinger, G. R. & Feldman, C. Montelukast inhibits neutrophil pro-inflammatory activity by a cyclic AMP-dependent mechanism. Br J Pharmacol 156, 105-115 (2009).
17. Anderson, R. et al. The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro. Mediators Inflamm 2014, 105420 (2014).
18. Curnutte, J. T., Erickson, R. W., Ding, J. & Badwey, J. A. Reciprocal interactions between protein kinase C and components of the NADPH oxidase complex may regulate superoxide production by neutrophils stimulated with a phorbol ester. J Biol Chem 269, 10813-10819 (1994).
19. Kranias, G. et al. Protein phosphatase 2A carboxymethylation and regulatory B subunits differentially regulate mast cell degranulation. Cell Signal 22, 1882-1890 (2010).
20. Lu, D. J., Takai, A., Leto, T. L. & Grinstein, S. Modulation of neutrophil activation by okadaic acid, a protein phosphatase inhibitor. Am J Physiol 262, C39-49 (1992).
21. Brechard, S. & Tschirhart, E. J. Regulation of superoxide production in neutrophils: role of calcium influx. J Leukoc Biol 84, 1223-1237 (2008).
22. Zhang, H. et al. STIM1 calcium sensor is required for activation of the phagocyte oxidase during inflammation and host defense. Blood 123, 2238-2249 (2014).
23. Tintinger, G. R., Steel, H. C., Theron, A. J. & Anderson, R. Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytes. Drug Des Devel Ther 2, 95-104 (2009).
24. Wang, Z. et al. Plasma neutrophil elastase and elafin imbalance is associated with acute respiratory distress syndrome (ARDS) development. PLoS One 4, e4380 (2009).
25. Korkmaz, B., Horwitz, M. S., Jenne, D. E. & Gauthier, F. Neutrophil elastase, proteinase 3, and cathepsinGas therapeutic targets in human diseases. Pharmacol Rev 62, 726-759 (2010).
26. Sandhaus, R. A. & Turino, G. Neutrophil elastase-mediated lung disease. COPD 10 Suppl 1, 60-63 (2013).
27. Ho, A. S. et al. Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers. Oncotarget 5, 473-480 (2014).
28. Talukdar, S. et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med 18, 1407-1412 (2012).
29. Witko-Sarsat, V., Rieu, P., Descamps-Latscha, B., Lesavre, P. & Halbwachs-Mecarelli, L. Neutrophils: molecules, functions and pathophysiological aspects. Lab Invest 80, 617-653 (2000).
30. Pham, C. T. Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 6, 541-550 (2006).
31. Futosi, K., Fodor, S. &Mocsai, A. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways. Int Immunopharmacol 17, 1185-1197 (2013).
32. Hirsch, E. et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287, 1049-1053 (2000).
33. Sasaki, T. et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration. Science 287, 1040-1046 (2000).
34. Traynor-Kaplan, A. E. et al. Transient increase in phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol trisphosphate during activation of human neutrophils. J Biol Chem 264, 15668-15673 (1989).
35. Fumagalli, L. et al. Class I phosphoinositide-3-kinases and SRC kinases play a nonredundant role in regulation of adhesion-independent and-dependent neutrophil reactive oxygen species generation. J Immunol 190, 3648-3660 (2013).
36. Liu, X. et al. Bidirectional regulation of neutrophil migration by mitogen-activated protein kinases. Nat Immunol 13, 457-464 (2012).
37. Kapui, Z. et al. Biochemical and pharmacological characterization of 2-(9-(2-piperidinoethoxy)-4-oxo-4H-pyrido[1,2-a]pyrimidin-2-yloxymethyl)-4-(1-met hylethyl)-6-methoxy-1,2-benzisothiazol-3(2H)-one-1,1-dioxide (SSR69071), a novel, orally active elastase inhibitor. J Pharmacol Exp Ther 305, 451-459 (2003).
38. Nakagawa, H., Kaneko, M., Watanabe, K., Sato, K. & Tsurufuji, S. Antiinflammatory effect of a selective inhibitor of elastase, cathepsin G and chymotrypsin on carrageenin-induced inflammation in rats. J Pharmacobiodyn 9, 432-435 (1986).
39. Michie, H. R. et al. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318, 1481-1486 (1988).
40. Yoshikawa, T., Takano, H., Takahashi, S., Ichikawa, H. & Kondo, M. Changes in tissue antioxidant enzyme activities and lipid peroxides in endotoxin-induced multiple organ failure. Circ Shock 42, 53-58 (1994).
41. Karima, R., Matsumoto, S., Higashi, H. & Matsushima, K. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 5, 123-132 (1999).
42. Tkalcevic, J. et al. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12, 201-210 (2000).
43. Hwang, T. L. et al. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway. Mol Pharmacol 64, 1419-1427 (2003).
44. Fujie, K. et al. Inhibition of elastase-induced acute inflammation and pulmonary emphysema in hamsters by a novel neutrophil elastase inhibitor FR901277. Inflamm Res 48, 160-167 (1999).